Missed detection of significant positive and negative shifts in gentamicin assay: implications for routine laboratory quality practices

INTRODUCTION: A product recall was issued for the Roche/Hitachi Cobas Gentamicin II assays on 25(th) May 2016 in Australia, after a 15 - 20% positive analytical shift was discovered. Laboratories were advised to employ the Thermo Fisher Gentamicin assay as an alternative. Following the reintroductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Koerbin, Gus, Liu, Jiakai, Eigenstetter, Alex, Tan, Chin Hon, Badrick, Tony, Loh, Tze Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2017
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701776/
https://www.ncbi.nlm.nih.gov/pubmed/29187798
http://dx.doi.org/10.11613/BM.2018.010705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701776/
https://www.ncbi.nlm.nih.gov/pubmed/29187798
http://dx.doi.org/10.11613/BM.2018.010705

Ejemplares similares